Go to content
Careers
News & Insights
Contact
Search
Strategy
Toggle submenu
The Acuitas Advantage
Our Partnerships
Our Capabilities
Science
Toggle submenu
Our LNP Technology
Our Clinical Applications
Company
Toggle submenu
About Us
Our Team
Our Community Impact
Home
News
Article
February 19, 2025
PUBLICATION ALERT: iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA